Kelly Shi
Stock Analyst at Jefferies
(3.24)
# 1,291
Out of 5,182 analysts
35
Total ratings
51.52%
Success rate
15.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Buy | $252 → $290 | $226.66 | +27.94% | 3 | Mar 16, 2026 | |
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $7.29 | +23.46% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $86.68 | +40.75% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $69.22 | +11.24% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $135.98 | +8.84% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $36.61 | -23.51% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $22.12 | +98.92% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $5.54 | +170.76% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.13 | +539.61% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.21 | +168.71% | 2 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $19 | $39.51 | -51.91% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $10.75 | +95.35% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.00 | +76.19% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $1.86 | +222.58% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $95.72 | -15.37% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $30.33 | +15.40% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.91 | +1,137.11% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $16.85 | -5.04% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $19.29 | +3.68% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $7.93 | +5,347.67% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.45 | +286.62% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.45 | +1,002.04% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $3.56 | +826.97% | 1 | Mar 8, 2021 |
Ascendis Pharma
Mar 16, 2026
Assumes: Buy
Price Target: $252 → $290
Current: $226.66
Upside: +27.94%
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $7.29
Upside: +23.46%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $86.68
Upside: +40.75%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $69.22
Upside: +11.24%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $135.98
Upside: +8.84%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $36.61
Upside: -23.51%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $22.12
Upside: +98.92%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $5.54
Upside: +170.76%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.13
Upside: +539.61%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.21
Upside: +168.71%
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $39.51
Upside: -51.91%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $10.75
Upside: +95.35%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $21.00
Upside: +76.19%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $1.86
Upside: +222.58%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $95.72
Upside: -15.37%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $30.33
Upside: +15.40%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.91
Upside: +1,137.11%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $16.85
Upside: -5.04%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $19.29
Upside: +3.68%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $7.93
Upside: +5,347.67%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.45
Upside: +286.62%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.45
Upside: +1,002.04%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $3.56
Upside: +826.97%